Regeneron has a drug that started human trials (i
Post# of 151566
they’d easily have results by now. Probably can crunch the #s and present the data most quickly as well...ugh
However, I think Cytodyn Mgmt is more savvy than the Armchair CEOs would give them credit for.. and aren’t telling us everything big picture.. I sure hope they’re getting us in with the FDA and Administration. Our EINDs and trials are small fries but hopefully the results show dramatic impact, the science is validated & we can’t be denied. We’ll sell out & even scale up considerably. Regardless of REG-COV2.
But given their securing the investment (as if they need it lol)... id give Regeneron a leg up vs us at this point until the data is released — either showing their drug marginally effective (likely) or Leronlimab highly effective.

